Replies to post #129608 on Biotech Values

[jq1234]

Gilead Submits New Drug Application to U.S. FDA for Once-Daily, Single-Tablet "Quad" HIV Regimen

http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle&ID=1622859&highlight=


It's extremely fast filing after 2nd pivotal trial result announced Sept. 19. Hopefully, they are not going to get RTF like Complera original filing:

http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle&ID=1519760&highlight=